Seaport Therapeutics doses first patient in anxiety disorder trial

October 7, 2026 1:00 PM

Seaport Therapeutics (Nasdaq: SPTX), a founded entity of PureTech Health (LSE: PRTC), announced that the first patient has been dosed ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found